Daniel Spratt, MD, is a radiation oncologist specializing in genitourinary radiation oncology. He serves as the Vincent K. Smith Endowed Chair and Professor in the Department of Radiation Oncology at Case Western Reserve University School of Medicine, and as Chair of the Department of Radiation Oncology at University Hospitals Cleveland Medical Center and UH Seidman Cancer Center. He also is Associate Chief Scientific Officer and Medical Director of the Clinical Research Center at University Hospitals and a member of the Case Comprehensive Cancer Center. Dr. Spratt’s clinical practice focuses on genitourinary oncology, advanced radiation therapy techniques including stereotactic body radiotherapy, and spine oncology within multidisciplinary cancer care. His research centers on precision oncology through genomic, molecular, and AI-driven biomarkers, optimization of radiotherapy and combination treatment strategies, and translational clinical trials designed to personalize care. A nationally recognized leader in the field, Dr. Spratt serves as Chair of the NCCN Prostate Cancer Guidelines Panel, Chair of the NRG Oncology Intact Prostate Cancer Subcommittee, a standing member of the FDA Oncology Drug Advisory Committee, and a member of the NCI Genitourinary Steering Committee. His honors include the ASTRO Steven A. Leibel Memorial Award, the NIH/NCI Cancer Clinical Investigator Team Leadership Award, and multiple teaching and clinical research awards. He earned his MD from Vanderbilt University School of Medicine, completed a transitional internship at Spartanburg Regional Healthcare System, and finished his residency in Radiation Oncology at Memorial Sloan Kettering Cancer Center.
Department Chair & Associate Chief Scientific Officer
Medical School
2006 – 2010
Residency
2010 – 2011